Use of therapeutic hypothermia for term infants with hypoxic-ischemic encephalopathy.
Newborn encephalopathy represents a clinical syndrome with diverse causes, many of which may result in brain injury. Hypoxic-ischemic encephalopathy represents a subset of newborns with encephalopathy and, in contrast to other causes, may have a modifiable outcome. Laboratory research has demonstrated robust neuroprotection associated with reductions of brain temperature following hypoxia-ischemia in animals. The neuroprotective effects of hypothermia reflect antagonism of multiple cascades of events that contribute to brain injury. Clinical trials have translated laboratory observations into successful interventions. Hypoxicischemic encephalopathy is often unanticipated, unavoidable, and may occur in any obstetric setting. Pediatricians and other providers based in community hospitals play a critical role in the initial assessment, recognition, and stabilization of infants who may be candidates for therapeutic hypothermia.
Laptook
Abbot R
AR
Neonatal Intensive Care Unit, Women and Infants' Hospital of Rhode Island, Warren Alpert Medical School at Brown University, Providence, RI 02905, USA. alaptook@wihri.org
D000818:Animals; D000831:Animals, Newborn; D002986:Clinical Trials as Topic; D049673:History, 20th Century; D006801:Humans; D007036:Hypothermia, Induced / Q000266:history / Q000379:methods*; D020925:Hypoxia-Ischemia, Brain / Q000628:therapy*; D007186:Incubators, Infant; D007231:Infant, Newborn; D013997:Time Factors